Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2023 , Vol 61 , Num 4
DBeQ-mediated pharmacological modulation of the retrotranslocation step of ERAD may exhibit a potent therapeutic approach against colorectal cancer
Yalcin ERZURUMLU 1 Hatice Kubra DOGAN 2
1 Department of Biochemistry, Faculty of Pharmacy, Suleyman Demirel University, 32260, Isparta, Türkiye
2 Department of Bioengineering, Institute of Science, Suleyman Demirel University, 32260, Isparta, Türkiye
DOI : 10.23893/1307-2080.APS6125 Keywords :

Istanbul Medipol University